» Articles » PMID: 18620555

Zinc Protoporphyrin IX, a Heme Oxygenase-1 Inhibitor, Demonstrates Potent Antitumor Effects but is Unable to Potentiate Antitumor Effects of Chemotherapeutics in Mice

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2008 Jul 16
PMID 18620555
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HO-1 participates in the degradation of heme. Its products can exert unique cytoprotective effects. Numerous tumors express high levels of HO-1 indicating that this enzyme might be a potential therapeutic target. In this study we decided to evaluate potential cytostatic/cytotoxic effects of zinc protoporphyrin IX (Zn(II)PPIX), a selective HO-1 inhibitor and to evaluate its antitumor activity in combination with chemotherapeutics.

Methods: Cytostatic/cytotoxic effects of Zn(II)PPIX were evaluated with crystal violet staining and clonogenic assay. Western blotting was used for the evaluation of protein expression. Flow cytometry was used to evaluate the influence of Zn(II)PPIX on the induction of apoptosis and generation of reactive oxygen species. Knock-down of HO-1 expression was achieved with siRNA. Antitumor effects of Zn(II)PPIX alone or in combination with chemotherapeutics were measured in transplantation tumor models.

Results: Zn(II)PPIX induced significant accumulation of reactive oxygen species in tumor cells. This effect was partly reversed by administration of exogenous bilirubin. Moreover, Zn(II)PPIX exerted potent cytostatic/cytotoxic effects against human and murine tumor cell lines. Despite a significant time and dose-dependent decrease in cyclin D expression in Zn(II)PPIX-treated cells no accumulation of tumor cells in G1 phase of the cell cycle was observed. However, incubation of C-26 cells with Zn(II)PPIX increased the percentage of cells in sub-G1 phase of the cells cycle. Flow cytometry studies with propidium iodide and annexin V staining as well as detection of cleaved caspase 3 by Western blotting revealed that Zn(II)PPIX can induce apoptosis of tumor cells. B16F10 melanoma cells overexpressing HO-1 and transplanted into syngeneic mice were resistant to either Zn(II)PPIX or antitumor effects of cisplatin. Zn(II)PPIX was unable to potentiate antitumor effects of 5-fluorouracil, cisplatin or doxorubicin in three different tumor models, but significantly potentiated toxicity of 5-FU and cisplatin.

Conclusion: Inhibition of HO-1 exerts antitumor effects but should not be used to potentiate antitumor effects of cancer chemotherapeutics unless procedures of selective tumor targeting of HO-1 inhibitors are developed.

Citing Articles

NADPH-Independent Fluorescent Probe for Live-Cell Imaging of Heme Oxygenase-1.

Li L, Lu X, He Q, Shu C, Walter E, Wang L ACS Sens. 2025; 10(1):499-506.

PMID: 39745434 PMC: 11773557. DOI: 10.1021/acssensors.4c02978.


Antioxidant Enzymes in Cancer Cells: Their Role in Photodynamic Therapy Resistance and Potential as Targets for Improved Treatment Outcomes.

Udomsak W, Kucinska M, Pospieszna J, Dams-Kozlowska H, Chatuphonprasert W, Murias M Int J Mol Sci. 2024; 25(6).

PMID: 38542138 PMC: 10969903. DOI: 10.3390/ijms25063164.


Deficiency of heme oxygenase 1a causes detrimental effects on cardiac function.

Wang H, Siren J, Perttunen S, Immonen K, Chen Y, Narumanchi S J Cell Mol Med. 2024; 28(7):e18243.

PMID: 38509740 PMC: 10955162. DOI: 10.1111/jcmm.18243.


Heme Oxygenase-1 and Its Role in Colorectal Cancer.

Fahrer J, Wittmann S, Wolf A, Kostka T Antioxidants (Basel). 2023; 12(11).

PMID: 38001842 PMC: 10669411. DOI: 10.3390/antiox12111989.


The dual role of heme oxygenase in regulating apoptosis in the nervous system of .

Abaquita T, Damulewicz M, Tylko G, Pyza E Front Physiol. 2023; 14:1060175.

PMID: 36860519 PMC: 9969482. DOI: 10.3389/fphys.2023.1060175.


References
1.
Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L . Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J. 2005; 19(14):1957-68. DOI: 10.1096/fj.05-3875com. View

2.
Sunamura M, Duda D, Ghattas M, Lozonschi L, Motoi F, Yamauchi J . Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis. 2003; 6(1):15-24. DOI: 10.1023/a:1025803600840. View

3.
Fang J, Sawa T, Akaike T, Greish K, Maeda H . Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer. 2004; 109(1):1-8. DOI: 10.1002/ijc.11644. View

4.
Loboda A, Jazwa A, Wegiel B, Jozkowicz A, Dulak J . Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells. Cell Mol Biol (Noisy-le-grand). 2005; 51(4):347-55. PMC: 1403815. View

5.
Berberat P, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Kunzli B . Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res. 2005; 11(10):3790-8. DOI: 10.1158/1078-0432.CCR-04-2159. View